Last reviewed · How we verify

NCT02910986

Behavioral and Psychological Impact of Returning Breast Density Results to Latinas

Completed NA Results posted Last updated 28 August 2025
What this trial tests

NA trial testing Written educational brochure in Breast Cancer in 1,386 participants. Completed in 15 November 2019.

Timeline
27 October 2016
Primary endpoint
15 November 2019
15 November 2019

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment1,386
Start date27 October 2016
Primary completion15 November 2019
Estimated completion15 November 2019
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

Adults 40 to 74, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Knowledge of Breast Density as a Masking Factor at First Follow-up Primary · Baseline (T0) to first follow-up (T1, 2 weeks to 180 days from education end)

Percentage of women who provided an incorrect response as to whether dense breasts impact the ability of a mammogram to correctly detect cancer at T0 but provided a correct response at T1 Comparisons of the difference between the intervention groups in percentage of women who provided an incorrect response as to whether dense breasts impact the ability of a mammogram to correctly detect cancer at T0 but provided a correct response to the question at T1

GroupValue95% CI
Enhanced101
Usual Care104
Interpersonal100
Anxiety Short Term (Baseline T0 to First Follow-up T1) Primary · Change from baseline anxiety (T0) to T1: 2 weeks to 180 days after education end

The State-Trait Anxiety Inventory-State (STAI-S) s a 20-item self-report assessment. Items are answered on a 4-point Likert scale ranging from 1 (not at all) to 4 (very much so), with the total score ranging from 20 to 80, with higher scores indicating higher levels of anxiety symptoms. Anxiety was dichotomized as: normal (STAI score \< 30) or moderate to severe (STAI score ≥ 30). The primary outcome was the percentage of participants who maintained or decreased to 'normal' anxiety levels at T1 from T0.

GroupValue95% CI
Usual Care99
Enhanced88
Interpersonal70
Usual Care100
Enhanced98
Interpersonal61
BC Risk Assessment - Survey Primary · T0 (baseline) to T1 (14 to 180 days after completion of education)

Percentage of women who provided incorrect response at baseline (T0) but a correct response at 14 to 180 days after completion of education to the question: 'Women who have dense breasts are at greater risk for getting breast cancer' (true, false, or I don't know). Comparisons of the difference in percentage of women who provided correct response to the single question: 'Women who have dense breasts are at greater risk for getting breast cancer' (true, false, or I don't know) between intervention groups.

GroupValue95% CI
Enhanced114
Usual Care110
Interpersonal95

Sponsor's own description

This study will examine behavioral and psychological outcomes of breast density notification using a 3-group randomized design comparing usual written notification to two educationally enhanced approaches.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Evaluating educational interventions to increase breast density awareness among Latinas: A randomized trial in a Federally Qualified Health Center.
    Ridgeway JL, Jenkins SM, Borah BJ, Suman VJ, et al · · 2022 · cited 9× · PMID 34855208 · DOI 10.1002/cncr.34017
  2. Behavioral and psychological impact of returning breast density results to Latinas: study protocol for a randomized clinical trial.
    Patel BK, Ridgeway JL, Ghosh K, Rhodes DJ, et al · · 2019 · cited 7× · PMID 31852492 · DOI 10.1186/s13063-019-3939-6
  3. Effectiveness of Breast Density Educational Interventions on Mammography Screening Adherence Among Underserved Latinas: A Randomized Controlled Trial.
    Austin JD, Jenkins SM, Suman VJ, Ridgeway JL, et al · · 2025 · cited 3× · PMID 39969957 · DOI 10.1089/jwh.2024.0273
  4. A randomized trial to evaluate the impact of breast density notification on anxiety, breast cancer worry, and perceived risk among Latinas at a federally qualified health center : Breast density notification and anxiety, breast cancer worry, and perceived risk among Latinas.
    Ghosh K, Jenkins SM, Ridgeway JL, Austin JD, et al · · 2025 · cited 2× · PMID 40452038 · DOI 10.1186/s12905-025-03818-9

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02910986.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing